Skip to main navigation Skip to search Skip to main content

A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED,MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF EXENATIDE ONCE WEEKLY IN ADOLESCENTS WITH TYPE 2 DIABETES

Project: Research

Project Details

StatusFinished
Effective start/end date10/25/16 → 12/31/21

Funding

  • Quintiles Incorporated: $115,706.00